BRPI0402756A - method for treating cognitive disorders - Google Patents

method for treating cognitive disorders

Info

Publication number
BRPI0402756A
BRPI0402756A BRPI0402756A BRPI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A BR PI0402756 A BRPI0402756 A BR PI0402756A
Authority
BR
Brazil
Prior art keywords
cognitive disorders
treating cognitive
carbamoylseroline
alzheimer
phenyl
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Nigel Greig
Gosse Bruinsma
Original Assignee
Axonyx Inc
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc, Us Gov Health & Human Serv filed Critical Axonyx Inc
Priority to BRPI0402756 priority Critical patent/BRPI0402756A/en
Publication of BRPI0402756A publication Critical patent/BRPI0402756A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO PARA O TRATAMENTO DE DISTúRBIOS COGNITIVOS". A presente invenção refere-se a composições e métodos para o tratamento de doenças que resultam de distúrbios cognitivos, tal como doença de Alzheimer com o composto (-)N-(-)-N fenil carbamoileserolina como o ingrediente ativo."METHOD FOR TREATMENT OF COGNITIVE DISORDERS". The present invention relates to compositions and methods for treating diseases resulting from cognitive disorders, such as Alzheimer's disease with the compound (-) N - (-) - N phenyl carbamoylseroline as the active ingredient.

BRPI0402756 2004-07-09 2004-07-09 method for treating cognitive disorders BRPI0402756A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0402756 BRPI0402756A (en) 2004-07-09 2004-07-09 method for treating cognitive disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0402756 BRPI0402756A (en) 2004-07-09 2004-07-09 method for treating cognitive disorders

Publications (1)

Publication Number Publication Date
BRPI0402756A true BRPI0402756A (en) 2006-02-21

Family

ID=36046266

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0402756 BRPI0402756A (en) 2004-07-09 2004-07-09 method for treating cognitive disorders

Country Status (1)

Country Link
BR (1) BRPI0402756A (en)

Similar Documents

Publication Publication Date Title
ECSP055719A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
UY28817A1 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGERATIVE DISORDERS
EP1841426A4 (en) Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
BR0315158A (en) Pyrazole Compounds for the Treatment of Neurodegenative Disorders
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
ATE389395T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE PREVENTIVE TREATMENT OF PARKINSON'S DISEASE
ATE489948T1 (en) TREATMENT OF AUTOIMMUNE DISEASES
DOP2005000049A (en) SULFONAMID COMPOUNDS FOR THE TREATMENT OF NEURODEGERERATIVE DISORDERS
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
UY28484A1 (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
BR0306855A (en) Method for the treatment of cognitive disorders
DE602005015697D1 (en) TE FOR THE TREATMENT OF ALZHEIMER DISEASE
MX2010000956A (en) Compounds which inhibit beta-secretase activity and methods of use thereof.
ATE402150T1 (en) PYRAZOLAMINE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
ECSP088280A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA200900269A1 (en) DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
EA200701584A1 (en) ORGANIC COMPOUNDS APPLICABLE FOR THE TREATMENT OF ALZHEIMER'S DISEASE, THEIR APPLICATION AND METHOD OF OBTAINING
DE502004006525D1 (en) USE OF FIGURE CACTUS (OPUNTIA) FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DEPRESSIONS
BRPI0507745A (en) substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, process for their preparation, medicaments and their uses
UY28458A1 (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
BRPI0402756A (en) method for treating cognitive disorders
BRPI0509881A (en) therapeutic combination for treatment of alzheimer's disease
ATE505193T1 (en) DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired